Thyroid Medication Recalled Nationwide: What to Do If Yours Is Affected

The Food and Drug Administration (FDA) issued a Class II nationwide recall of levothyroxine, a common thyroid medication. hudiemm/Getty Images A common thyroid medication is under a voluntary recall after testing found it was less potent than expected. The FDA classified a nationwide recall of levothyroxine sodium tablets as Class II on July 17 after testing found the pills were subpotent, according to the agency’s enforcement report. Those who have been prescribed the medication are encouraged to continue taking it, and pharmacies are not required to notify patients. Some people taking a common thyroid medication may have been getting a weaker dose than their doctors prescribed.The Food and Drug Administration (FDA) classified a nationwide recall of levothyroxine sodium tablets as Class II on July 17 after routine testing found the tablets were subpotent. This means the pills don’t contain the full dose printed on the package, according to the FDA’s enforcement report. An FDA Class II recall is considered a medium-risk recall that may lead to temporary or reversible health problems, with a low probability of serious harm. The recall includes seven strengths, fro…